This product entry features the Borax Combo, a specialized multi-component chemical formulation developed exclusively as a generic, brandless material to support standardized laboratory investigations. Named after its original open-source design architecture, this combination matrix integrates fixed, calculated ratios of an entactogen agent, a psychostimulant, and a selective tryptamine derivative. Each isolated constituent within the composite blend is refined to an exact chemical baseline of ≥98% purity. By providing these specific reference reagents as a unified, homogenous formulation, laboratories can avoid the measurements and mechanical errors associated with blending distinct chemical profiles for baseline in vitro assays.
Wikipedia

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The Borax Combo does not contain, nor is it structurally related to, industrial sodium borate or household borax compounds; it is a complex array of regulated research reagents requiring professional containment.
Wikipedia

Chemical Identity & Classification
To maintain absolute transparency and strict compliance within verified research facilities, the active chemical entities comprising the Borax Combo matrix are documented below:

Component A (Entactogen): 1-(Benzofuran-5-yl)-N-methylpropan-2-amine (5-MAPB) | CAS: 1354631-77-8
Wikipedia

Component B (Stimulant): 1-(2-Fluorophenyl)-N-methylpropan-2-amine (2-FMA) | CAS: 1780004-19-4

Component C (Tryptamine): 5-Methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT) | CAS: 96096-55-8

Formulation Format: Fixed-ratio analytical powder or compressed matrix containing precise, micro-gram validated allocations of each active agent.

Primary Classification: Combined monoaminergic reagent matrix, complex multi-receptor profiling reference material.

Chemical & Physical Characteristics
In its standard consolidated state, the Borax Combo presents as a uniform, off-white to light gray crystalline powder or highly stable compressed solid mass. The active components are structurally integrated within an optimized salt matrix (typically utilizing hydrochloride or succinate salt forms) to maximize thermal stability and resist humidity-induced clumping. The physical blend is designed for neutral storage and exhibits a predictable degradation curve under standard environmental stressors. Solubility is highly pronounced in polar organic solvents, showing rapid dissolution in dimethyl sulfoxide (DMSO), anhydrous methanol, and dimethylformamide (DMF), which allows for smooth dilution into liquid chromatography mobile phases.

Purity & Analytical Verification
Every constituent chemical utilized in the preparation of the Borax Combo meets or exceeds a mandatory analytical threshold of ≥98% purity. To verify that no unreacted intermediate precursors, synthetic byproducts, or positional isomers compromise the integrity of downstream laboratory testing, each batch is processed through a strict multi-instrument testing pipeline:

High-Performance Liquid Chromatography (HPLC): Deployed to map individual retention times and confirm the absolute quantity ratios of each active agent within the matrix.

Gas Chromatography-Mass Spectrometry (GC-MS / LC-MS): Utilized to verify the precise molecular weight and structural fragmentation fingerprint of each compound.

Nuclear Magnetic Resonance (NMR) Spectroscopy: Applied to guarantee structural isomer confirmation, ensuring the absolute 5-position orientation of the benzofuran and the proper positioning of the tryptamine side-chains.

A certified Certificate of Analysis (COA) mapping these multi-tiered verification data points is logged with every production lot.

Quality Control & Batch Integrity
Production of the Borax Combo is executed under strict, batch-controlled laboratory conditions to minimize variance across independent production lots. Each mixture is assigned a unique, trackable lot number that provides direct traceability back to the initial raw component lots. Our internal quality control oversight guarantees thorough homogenization of the constituents, preventing localized imbalances or concentration gradients within the final packaging. The generic, unbranded nature of this product ensures that research entities receive unadulterated reference materials completely optimized for industrial R&D replication.

Safety, Handling & Laboratory Precautions
The Borax Combo represents a highly potent mixture of uncharacterized neurochemical reagents and must be treated with absolute caution. Qualified personnel must deploy complete personal protective equipment (PPE) during all experimental phases, including heavy-duty nitrile laboratory gloves, certified safety glasses with side shields, and specialized protective lab coats.

Because the formulation contains high-potency tryptamine and amphetamine derivatives, all transfers, measuring, and solution preparation must occur within a certified chemical fume hood or localized negative-pressure containment unit to eliminate any threat of airborne particle inhalation. Prior to opening the material, researchers must review the respective Safety Data Sheets (SDS) for each constituent compound.

Packaging, Labeling & Storage
To protect the individual chemical bonds within the composite from early thermal cleavage or photo-oxidation, the mixture is sealed in heavy-duty, laboratory-grade packaging. Primary containment relies on airtight, amber glass vials or UV-resistant high-density polyethylene (HDPE) containers complete with tamper-resistant security seals. The outer labeling features comprehensive compliance documentation, showcasing all applicable CAS numbers, active ingredient designations, production batch tracking IDs, and stark notices prohibiting non-laboratory use. To ensure long-term stability, keep the container hermetically sealed and stored in a laboratory freezer maintained continuously at or below -20°C.

Intended Research Use & Market Positioning
This multi-component reagent is positioned on the market strictly as an advanced screening tool for forensic laboratories, receptor mapping facilities, and academic neurochemical R&D sectors. Its primary utility lies in the simultaneous in vitro evaluation of multi-transporter kinetics, allowing researchers to study concurrent serotonin, dopamine, and norepinephrine release mechanisms without deploying multiple independent reference standards. It is entirely banned from any veterinary, clinical diagnostic, agricultural, or consumer applications.

Ordering, Availability & Fulfillment
Our eCommerce platform maintains continuous inventory oversight to provide predictable availability for institutional purchase cycles. The secure checkout pipeline utilizes advanced data encryption frameworks to remain fully aligned with international banking standards and payment processor compliance reviews. Once institutional authorization is completed, products are dispatched in ruggedized, non-descript external packaging designed to maintain transit safety and protect sample integrity. All logistical documentation and tracked shipping barcodes are delivered immediately to your procurement team.

Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. This product is a generic chemical matrix containing specialized reagents intended solely for verified laboratory research conducted by qualified professionals. The purchasing organization assumes full, unshared responsibility for verifying the legal, scheduling, and import status of 5-MAPB, 2-FMA, and 5-MeO-MiPT within their distinct local, national, or municipal jurisdictions before finalizing a transaction. The vendor assumes no liability for custom seizures, domestic legal violations, or damages stemming from unauthorized handling or non-compliant use.